4.6 Article

Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: Evidence for a role in pain

Journal

PAIN
Volume 139, Issue 1, Pages 90-105

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1016/j.pain.2008.03.016

Keywords

ATP; Keratinocytes; Pain; Skin; Voltage-gated Sodium Channels

Funding

  1. Medical Research and Rehabilitation Research Services, Department of Veterans Affairs
  2. NIH [NS34692]
  3. VZV Research Foundation
  4. Ruth C. Rosenblatt Fund

Ask authors/readers for more resources

Keratinocytes are implicated in sensory transduction and can influence nociception, but whether these contribute to chronic pain is not known. In neurons, voltage-gated sodium channels(Na-v) are involved in neuropathic pain and are activated by depolarization. Since keratinocytes can also show changes in membrane potential. We used RT-PCR, in situ hybridization, and immunohistochemistry to investigate the expression of sodium channels contribute to the release of ATP from rat keratinocytes in response to increased [K+](o), implicating sodium channels in keratinocyte ligand release and nociception. To examine whether keratinocytes may contribute to human pain states, we analyzed sodium channel expression in human skin biopsies from subjects with complex regional pain syndrome Type 1 (CRPS) and post- herpetic neuralgia (PHN) using immunohistochemistry. Control skin exhibited immunolabeling for Na(v)1.5, Na(v)1.6, Na(v)1.7. In contrast, painful skin from CRPS and PHN subjects displayed Na(v)1.1, Na(v)1.2, Na(v)1.8, immunolabeling, in addition to substantially increased signal for Na(v)1.5, Na(v)1.6, Na(v)1.75. These observations lead us to propose that pathological increases in keratinocyte sodium channel expression may contribute to pain by increasing epidermal ATP release, resulting in excessive activation of P2X receptor on primary sensory axons. Consistent with this hypothesis, animal models of neuropathic pain exhibit increases in subcutaneous ATP release and activity of primary sensory neurons, and peripheral administration of P2X antagonists has been shown to reduce neuropathic pain in humans. (C) 2008 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available